Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma-Reference-Cited by-同舟云学术

Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma

Published:2019-07-18 Issue:3 Volume:105 Page:e116-e120
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Algarín Esperanza M,Díaz-Tejedor Andrea,Mogollón Pedro,Hernández-García Susana,Corchete Luis A.,San-Segundo Laura,Martín-Sánchez Montserrat,González-Méndez Lorena,Schoumacher Marie,Banquet Sebastien,Kraus-Berthier Laurence,Kloos Ioana,Derreal Alix,Halilovic Ensar,Maacke Heiko,Gutiérrez Norma C.,Mateos María-Victoria,Paíno Teresa,Garayoa Mercedes,Ocio Enrique M.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision medicine for multiple myeloma: The case for translocation (11;14);Cancer Treatment Reviews;2024-11

2. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential;Biomedicine & Pharmacotherapy;2024-06

3. Development of recombinant protein-based nanoparticle systems for inducing tumor cell apoptosis: In vitro evaluation of their cytotoxic and apoptotic effects on cancer cells;Journal of Drug Delivery Science and Technology;2024-05

4. Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity;Frontiers in Oncology;2024-04-08

5. Dual targeting of Mcl-1 and Bcl-2 to overcome chemoresistance in cervical and colon cancer;Anti-Cancer Drugs;2023-11-13